GlassScriptPhysician profile
Lindsey Noel Collins
NPI 1033782735
$1,156.68
in general payments reported to CMS, 2019-2025
13 companies · $462 in 2025
The $462 reported for 2025 was more than what 84% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.57 · 2023: $253 · 2024: $419 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.18 |
| Education | $275.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $575.35 | 2023-2025 | Veozah |
| Organon LLC | $115.66 | 2024-2025 | Nexplanon |
| Axonics, INC. | $99.55 | 2024 | Axonics |
| Sage Therapeutics, LLC | $68.41 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $66.80 | 2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $61.32 | 2022-2023 | |
| Exeltis, USA INC. | $46.72 | 2024-2025 | Slynd |
| Abbvie INC. | $22.11 | 2023 | |
| Dynavax Technologies Corporation | $20.89 | 2023 | Heplisav-B |
| Davol INC. | $20.47 | 2023 | Arista Ah Flexitip |
| Supernus Pharmaceuticals, INC. | $20.17 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $19.96 | 2024 | |
| Coopersurgical, INC. | $19.27 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.